This is a Validated Antibody Database (VAD) review about human fatty acid synthase, based on 96 published articles (read how Labome selects the articles), using fatty acid synthase antibody in all methods. It is aimed to help Labome visitors find the most suited fatty acid synthase antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
fatty acid synthase synonym: FAS; OA-519; SDR27X1

Knockout validation
Abcam
domestic rabbit monoclonal (EPR7466)
  • western blot knockout validation; human; 1:2000; loading ...
Abcam fatty acid synthase antibody (Abcam, ab128870) was used in western blot knockout validation on human samples at 1:2000. Nat Metab (2020) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (C20G5)
  • western blot knockout validation; human; 1:1000; fig 1e
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling Technology, 3180S) was used in western blot knockout validation on human samples at 1:1000 (fig 1e). Nat Metab (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (C20G5)
  • immunohistochemistry knockout validation; mouse; 1:50; loading ...; fig 6a
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 6a
  • western blot; mouse; 1:1000; loading ...; fig s1d
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in immunohistochemistry knockout validation on mouse samples at 1:50 (fig 6a), in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 6a) and in western blot on mouse samples at 1:1000 (fig s1d). Nat Commun (2019) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (C20G5)
  • immunohistochemistry knockout validation; mouse; 1:500; loading ...; fig 1c
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling Technology, 3180) was used in immunohistochemistry knockout validation on mouse samples at 1:500 (fig 1c). Gut (2020) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A-5)
  • western blot; mouse; 1:1000; loading ...; fig 3b
Santa Cruz Biotechnology fatty acid synthase antibody (Santa, sc-55580) was used in western blot on mouse samples at 1:1000 (fig 3b). Nat Commun (2020) ncbi
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology fatty acid synthase antibody (SantaCruz, H-300) was used in western blot on human samples (fig 2a). Mol Psychiatry (2018) ncbi
  • western blot; mouse; 1:1000; loading ...; fig s2b
Santa Cruz Biotechnology fatty acid synthase antibody (Santa, H-300) was used in western blot on mouse samples at 1:1000 (fig s2b). Nat Commun (2018) ncbi
mouse monoclonal (G-11)
  • immunohistochemistry; mouse; 1:100; loading ...; fig e3c
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, sc48357) was used in immunohistochemistry on mouse samples at 1:100 (fig e3c). Nature (2018) ncbi
mouse monoclonal (A-5)
  • western blot; human; loading ...; fig s7
  • western blot; mouse; loading ...; fig s9a
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, sc-55580) was used in western blot on human samples (fig s7) and in western blot on mouse samples (fig s9a). Sci Signal (2017) ncbi
mouse monoclonal (A-5)
  • western blot; mouse; loading ...; fig 5A
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, sc-55580) was used in western blot on mouse samples (fig 5A). Int J Mol Med (2017) ncbi
  • western blot; human; loading ...; fig 6a
In order to find that a subset of SLC25A46 interacts with mitochondrial dynamics components and the MICOS complex, Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, H-300) was used in western blot on human samples (fig 6a). Mol Biol Cell (2017) ncbi
  • immunocytochemistry; human; loading ...; fig s3b
  • western blot; human; loading ...; fig s2f
Santa Cruz Biotechnology fatty acid synthase antibody (SantaCruz, H-300) was used in immunocytochemistry on human samples (fig s3b) and in western blot on human samples (fig s2f). J Cell Biol (2016) ncbi
  • western blot; mouse; 1:500; loading ...; fig 5b
In order to study cancer-testis antigen expression in a mouse model of prostate cancer, Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, H-300) was used in western blot on mouse samples at 1:500 (fig 5b). Prostate (2017) ncbi
  • western blot; mouse; loading ...; fig 1b
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz Biotechnology, H-300) was used in western blot on mouse samples (fig 1b). Sci Rep (2016) ncbi
  • western blot; mouse; loading ...; fig 2a
In order to assess cyclic alterations of lipid metabolism over a 24-hour period after binge in small heterodimer partner nuclear receptor knockout mice, Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, sc-20140) was used in western blot on mouse samples (fig 2a). Am J Pathol (2016) ncbi
mouse monoclonal (A-5)
  • western blot; rat; loading ...; fig 9a
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, sc-55580) was used in western blot on rat samples (fig 9a). Redox Biol (2016) ncbi
  • immunohistochemistry - paraffin section; human; 8 ug/ml; loading ...; fig 1a
In order to test if EGR 1 regulates prostate field effect formation by controlling PDGF A, MIC 1, and FASN expression, Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, sc20140) was used in immunohistochemistry - paraffin section on human samples at 8 ug/ml (fig 1a). Int J Oncol (2016) ncbi
mouse monoclonal (A-5)
  • western blot; human; fig 5
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, 55580) was used in western blot on human samples (fig 5). BMC Complement Altern Med (2016) ncbi
  • western blot; mouse; loading ...; fig 3h
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, sc-20140) was used in western blot on mouse samples (fig 3h). J Lipid Res (2016) ncbi
  • western blot; rat; 1:1000; loading ...; fig 7c
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, H-300) was used in western blot on rat samples at 1:1000 (fig 7c). PLoS ONE (2016) ncbi
  • western blot; human; loading ...; fig 3c
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, H-300) was used in western blot on human samples (fig 3c). Oncotarget (2016) ncbi
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology fatty acid synthase antibody (SCBT, H-300) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (A-5)
  • western blot; human; fig 2
In order to elucidate the mechanism of intracellular activation of EGFR by fatty acid synthase dependent palmitoylation, Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz Biotechnology, sc-55580) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (A-5)
  • western blot; rat
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, sc-55580) was used in western blot on rat samples . Cell Physiol Biochem (2015) ncbi
mouse monoclonal (A-5)
  • western blot; mouse; fig 7
  • western blot; human; fig 7
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, sc-55580) was used in western blot on mouse samples (fig 7) and in western blot on human samples (fig 7). Oncogene (2016) ncbi
mouse monoclonal (A-5)
  • western blot; human; 0.3 ug/ml; fig s6c
Santa Cruz Biotechnology fatty acid synthase antibody (Santa cruz, sc-55580) was used in western blot on human samples at 0.3 ug/ml (fig s6c). Mol Cancer (2015) ncbi
  • western blot; human; 1:1000; loading ...; fig 1c
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, H-300) was used in western blot on human samples at 1:1000 (fig 1c). DNA Repair (Amst) (2015) ncbi
  • western blot; mouse; loading ...; fig s3a
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz Biotechnology, H-300) was used in western blot on mouse samples (fig s3a). Cell Death Differ (2015) ncbi
mouse monoclonal (A-5)
  • western blot; human; fig 5b
Santa Cruz Biotechnology fatty acid synthase antibody (santa cruz, sc-55580) was used in western blot on human samples (fig 5b). Int J Mol Med (2015) ncbi
mouse monoclonal (A-5)
  • immunohistochemistry - paraffin section; human; fig 4
  • immunoprecipitation; human; fig 5
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 4
In order to analyze EGF induced mitochondrial fusion of cancer cells created by de novo synthesized palmitate and mitochondrial EGFR, Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, sc-55580) was used in immunohistochemistry - paraffin section on human samples (fig 4), in immunoprecipitation on human samples (fig 5), in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 4). Cell Cycle (2014) ncbi
mouse monoclonal (G-11)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 1
Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz, sc-48357) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1). Stem Cell Reports (2014) ncbi
mouse monoclonal (G-11)
  • immunohistochemistry - frozen section; mouse
In order to examine the role of keratin 76 in tight junction function and maintenance of the skin barrier, Santa Cruz Biotechnology fatty acid synthase antibody (Santa Cruz Biotechnology, sc-48357) was used in immunohistochemistry - frozen section on mouse samples . PLoS Genet (2014) ncbi
Abcam
domestic rabbit monoclonal (EPR7465)
  • western blot; mouse; fig 9f
Abcam fatty acid synthase antibody (Abcam, AB128856) was used in western blot on mouse samples (fig 9f). PLoS Biol (2021) ncbi
domestic rabbit monoclonal (EPR7465)
  • western blot; human; 1:1000; loading ...; fig 6g
Abcam fatty acid synthase antibody (Abcam, Ab128856) was used in western blot on human samples at 1:1000 (fig 6g). NPJ Breast Cancer (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
  • western blot; human; fig 2
Abcam fatty acid synthase antibody (Abcam, ab22759) was used in immunohistochemistry - paraffin section on human samples (fig 1a) and in western blot on human samples (fig 2). Front Pharmacol (2021) ncbi
domestic rabbit monoclonal (EPR7466)
  • western blot knockout validation; human; 1:2000; loading ...
Abcam fatty acid synthase antibody (Abcam, ab128870) was used in western blot knockout validation on human samples at 1:2000. Nat Metab (2020) ncbi
domestic rabbit polyclonal
  • western blot; bovine; loading ...; fig 3a
Abcam fatty acid synthase antibody (Abcam, ab22759) was used in western blot on bovine samples (fig 3a). Biomed Res Int (2019) ncbi
domestic rabbit monoclonal (EPR7466)
  • western blot; mouse; loading ...; fig 1b
Abcam fatty acid synthase antibody (Abcam, ab128870) was used in western blot on mouse samples (fig 1b). EMBO J (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 1f
In order to investigate the contribution of liver receptor homolog 1 SUMOylation to nonalcoholic fatty liver disease development, Abcam fatty acid synthase antibody (Abcam, ab22759) was used in western blot on mouse samples (fig 1f). J Clin Invest (2017) ncbi
domestic rabbit monoclonal (EPR7466)
  • western blot; mouse; loading ...; fig 3g
Abcam fatty acid synthase antibody (Abcam, ab128870) was used in western blot on mouse samples (fig 3g). Cell Death Dis (2016) ncbi
domestic rabbit polyclonal
  • proximity ligation assay; human; loading ...; fig 1b
  • immunoprecipitation; human; loading ...; fig 1a
  • immunocytochemistry; human; loading ...; fig 1d
  • western blot; human; 1 ug/ml; loading ...; fig 1a
  • proximity ligation assay; mouse; loading ...; fig 1h
  • immunocytochemistry; mouse; loading ...; fig 1f
  • western blot; mouse; 1 ug/ml; loading ...; fig s4c
Abcam fatty acid synthase antibody (Abcam, ab22759) was used in proximity ligation assay on human samples (fig 1b), in immunoprecipitation on human samples (fig 1a), in immunocytochemistry on human samples (fig 1d), in western blot on human samples at 1 ug/ml (fig 1a), in proximity ligation assay on mouse samples (fig 1h), in immunocytochemistry on mouse samples (fig 1f) and in western blot on mouse samples at 1 ug/ml (fig s4c). Nat Immunol (2016) ncbi
domestic rabbit monoclonal (EPR7466)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to analyze metastatic breast cancer and the expression of lipid metabolism-related proteins, Abcam fatty acid synthase antibody (Abcam, ab128870) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (EPR7466)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
  • western blot; human; fig 1
In order to characterize different breast cancer subtypes and differential expression of lipid metabolism-related proteins, Abcam fatty acid synthase antibody (Abcam, ab128870) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2) and in western blot on human samples (fig 1). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (EPR7466)
  • western blot; mouse
Abcam fatty acid synthase antibody (Abcam, ab128870) was used in western blot on mouse samples . J Lipid Res (2013) ncbi
Novus Biologicals
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:100; fig 3
  • western blot; human; 1:1000; fig 3
Novus Biologicals fatty acid synthase antibody (Novus, NB400-114) was used in immunocytochemistry on human samples at 1:100 (fig 3) and in western blot on human samples at 1:1000 (fig 3). Nat Commun (2016) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3e
Cell Signaling Technology fatty acid synthase antibody (CST, 3189) was used in immunohistochemistry - paraffin section on mouse samples (fig 3e). Cell Mol Gastroenterol Hepatol (2022) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; human; 1:1000; loading ...; fig 5a
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling Technology, C20G5) was used in western blot on human samples at 1:1000 (fig 5a). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot knockout validation; human; 1:1000; fig 1e
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling Technology, 3180S) was used in western blot knockout validation on human samples at 1:1000 (fig 1e). Nat Metab (2021) ncbi
domestic rabbit monoclonal (C20G5)
  • immunohistochemistry; mouse; 1:200; fig 3a
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling Technology, 3180) was used in immunohistochemistry on mouse samples at 1:200 (fig 3a). J Cell Mol Med (2021) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; loading ...; fig 3j
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling Technology, 3180S) was used in western blot on mouse samples (fig 3j). Front Pharmacol (2021) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; human; 1:1000; loading ...; fig 4b
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on human samples at 1:1000 (fig 4b). Nat Commun (2021) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; loading ...; fig 3a
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180S) was used in western blot on mouse samples (fig 3a). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; 1:1000; loading ...; fig 4a, 4c
  • western blot; human; 1:1000; loading ...; fig 4d
Cell Signaling Technology fatty acid synthase antibody (CST, 3180) was used in western blot on mouse samples at 1:1000 (fig 4a, 4c) and in western blot on human samples at 1:1000 (fig 4d). Nat Commun (2021) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; 1:1000; loading ...; fig 2a
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on mouse samples at 1:1000 (fig 2a). Commun Biol (2021) ncbi
domestic rabbit monoclonal (C20G5)
  • immunohistochemistry - paraffin section; human; 1:30; fig 1e
Cell Signaling Technology fatty acid synthase antibody (CST, 3180) was used in immunohistochemistry - paraffin section on human samples at 1:30 (fig 1e). Oncogene (2021) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; human; loading ...; fig 5c
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling Technology, 3180S) was used in western blot on human samples (fig 5c). Cancer Res (2020) ncbi
domestic rabbit monoclonal (C20G5)
  • immunohistochemistry knockout validation; mouse; 1:50; loading ...; fig 6a
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 6a
  • western blot; mouse; 1:1000; loading ...; fig s1d
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in immunohistochemistry knockout validation on mouse samples at 1:50 (fig 6a), in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 6a) and in western blot on mouse samples at 1:1000 (fig s1d). Nat Commun (2019) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; rat; 1:1000; loading ...; fig 3e
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on rat samples at 1:1000 (fig 3e). Am J Physiol Regul Integr Comp Physiol (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 6e
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling Technology, 3189) was used in western blot on mouse samples (fig 6e). Cell Metab (2019) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; human; 1:1000; loading ...; fig 6b
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling Technology, 3180) was used in western blot on human samples at 1:1000 (fig 6b). Mol Med Rep (2019) ncbi
domestic rabbit monoclonal (C20G5)
  • immunohistochemistry knockout validation; mouse; 1:500; loading ...; fig 1c
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling Technology, 3180) was used in immunohistochemistry knockout validation on mouse samples at 1:500 (fig 1c). Gut (2020) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; loading ...; fig s2g, s4a
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on mouse samples (fig s2g, s4a). Cell (2018) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; human; loading ...; fig 6b
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on human samples (fig 6b). FEBS Lett (2018) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; 1:1000; loading ...; fig s2b
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on mouse samples at 1:1000 (fig s2b). Nat Commun (2018) ncbi
domestic rabbit monoclonal (C20G5)
  • other; human; loading ...; fig 4c
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; loading ...; fig 2b
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180S) was used in western blot on mouse samples (fig 2b). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit monoclonal (C20G5)
  • immunocytochemistry; human; loading ...; fig 1a
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, C20G5) was used in immunocytochemistry on human samples (fig 1a). Mol Cell Biol (2017) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; human; 1:1000; loading ...; fig 8b
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on human samples at 1:1000 (fig 8b). Toxicol Appl Pharmacol (2017) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; 1:500; loading ...; fig 3c
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on mouse samples at 1:500 (fig 3c). J Biol Chem (2017) ncbi
domestic rabbit monoclonal (C20G5)
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology fatty acid synthase antibody (CST, 3180) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit monoclonal (C20G5)
  • immunohistochemistry - paraffin section; mouse; 1:150; loading ...; fig 4
In order to test if de novo lipogenesis is required for liver carcinogenesis, Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in immunohistochemistry - paraffin section on mouse samples at 1:150 (fig 4). Cell Cycle (2017) ncbi
domestic rabbit monoclonal (C20G5)
  • reverse phase protein lysate microarray; human; loading ...; fig 3a
In order to describe the features of 228 primary cervical cancers, Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in reverse phase protein lysate microarray on human samples (fig 3a). Nature (2017) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; human; loading ...; fig 4i
Cell Signaling Technology fatty acid synthase antibody (CST, 3180) was used in western blot on human samples (fig 4i). Nature (2017) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; 1:1000; loading ...; fig 7a
In order to analyze the effect of a high-fat diet on liver morphology and physiology, lipid metabolism, immune signaling, energy homeostasis, and stress responses during acute Trypanosoma cruzi infection, Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, C20G5) was used in western blot on mouse samples at 1:1000 (fig 7a). Parasitol Res (2017) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on human samples at 1:1000 (fig 6a). Arch Biochem Biophys (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 6a
In order to discuss how c-jun regulates astrocyte elevated gene-1 in gliomas, Cell Signaling Technology fatty acid synthase antibody (Cell signaling, 3189) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 6a). Mol Cell Biol (2017) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; fig 3
In order to identify and characterize a biliverdin reductase A-glycogen synthase kinase 3beta-peroxisome proliferator-activated receptor alpha axis that regulates hepatic lipid metabolism, Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180S) was used in western blot on mouse samples (fig 3). J Biol Chem (2016) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; 1:1000; loading ...
In order to study the role of endothelial cell exocytosis in cerebral cavernous malformation disease progression, Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on mouse samples at 1:1000. Nat Med (2016) ncbi
domestic rabbit monoclonal (C20G5)
  • proximity ligation assay; human; loading ...; fig 1b
  • immunoprecipitation; human; loading ...; fig 1a
  • immunocytochemistry; human; loading ...; fig 1d
  • western blot; human; 1:1000; loading ...; fig 1a
  • proximity ligation assay; mouse; loading ...; fig 1h
  • immunocytochemistry; mouse; loading ...; fig 1f
  • western blot; mouse; 1:1000; loading ...; fig s4c
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in proximity ligation assay on human samples (fig 1b), in immunoprecipitation on human samples (fig 1a), in immunocytochemistry on human samples (fig 1d), in western blot on human samples at 1:1000 (fig 1a), in proximity ligation assay on mouse samples (fig 1h), in immunocytochemistry on mouse samples (fig 1f) and in western blot on mouse samples at 1:1000 (fig s4c). Nat Immunol (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 5
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3189) was used in western blot on mouse samples (fig 5). Int J Mol Med (2016) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; human; loading ...; fig 3e
In order to find strategies to suppress glioblastoma growth via sterol regulatory element-binding protein-1 inhibition, Cell Signaling Technology fatty acid synthase antibody (Cell signaling, 3180) was used in western blot on human samples (fig 3e). Clin Cancer Res (2016) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; 1:1000; fig 4
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on mouse samples at 1:1000 (fig 4). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; fig 3
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling Tech, 3189) was used in western blot on mouse samples at 1:500 (fig 3). J Am Heart Assoc (2016) ncbi
domestic rabbit monoclonal (C20G5)
  • immunohistochemistry; mouse; 1:100; fig 3d
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in immunohistochemistry on mouse samples at 1:100 (fig 3d). Sci Rep (2016) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; 1:1000; fig s8
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on mouse samples at 1:1000 (fig s8). Nat Commun (2015) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; 1:1000; fig 4
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on mouse samples at 1:1000 (fig 4). Nat Commun (2015) ncbi
domestic rabbit monoclonal (C20G5)
  • immunohistochemistry; human; loading ...; fig 2c
  • western blot; mouse; fig 8a
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in immunohistochemistry on human samples (fig 2c) and in western blot on mouse samples (fig 8a). EMBO Rep (2015) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; 1:1000; fig 2
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on mouse samples at 1:1000 (fig 2). Br J Pharmacol (2015) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse
In order to examine the role of coregulators of nuclear receptor action in thyroid hormone action, Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, C20G5) was used in western blot on mouse samples . Mol Cell Biol (2015) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; human
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse
In order to investigate the effect of chronic beta3-adrenergic receptor activation on lipolysis and de novo lipogenesis in brown, beige, and white adipose tissues, Cell Signaling Technology fatty acid synthase antibody (Cell Signal, 3180) was used in western blot on mouse samples . J Lipid Res (2014) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; human; 1:1000
Cell Signaling Technology fatty acid synthase antibody (CST, 3180) was used in western blot on human samples at 1:1000. J Agric Food Chem (2014) ncbi
domestic rabbit monoclonal (C20G5)
  • western blot; mouse; 1:1000; fig s10e
Cell Signaling Technology fatty acid synthase antibody (Cell Signaling, 3180S) was used in western blot on mouse samples at 1:1000 (fig s10e). Nat Commun (2013) ncbi
domestic rabbit monoclonal (C20G5)
  • immunohistochemistry - paraffin section; mouse
  • western blot; mouse
Cell Signaling Technology fatty acid synthase antibody (Cell Signalling, 3180) was used in immunohistochemistry - paraffin section on mouse samples and in western blot on mouse samples . PLoS ONE (2013) ncbi
BD Biosciences
mouse monoclonal (23/Fatty Acid Synthase)
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4
BD Biosciences fatty acid synthase antibody (BD BioSciences, 610962) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4). Cells (2021) ncbi
mouse monoclonal (23/Fatty Acid Synthase)
  • western blot; human; 1:2000; loading ...; fig 3c
BD Biosciences fatty acid synthase antibody (BD Biosciences, 610963) was used in western blot on human samples at 1:2000 (fig 3c). Cell Mol Gastroenterol Hepatol (2021) ncbi
mouse monoclonal (23/Fatty Acid Synthase)
  • western blot; rat; fig 5
BD Biosciences fatty acid synthase antibody (BD Transduction Laboratories, 610962) was used in western blot on rat samples (fig 5). Physiol Rep (2016) ncbi
mouse monoclonal (23/Fatty Acid Synthase)
  • western blot; human; fig 2
BD Biosciences fatty acid synthase antibody (BD, 610962) was used in western blot on human samples (fig 2). Traffic (2016) ncbi
mouse monoclonal (23/Fatty Acid Synthase)
  • western blot; mouse; 1:2000; fig 4
BD Biosciences fatty acid synthase antibody (BD Biosciences, 610963) was used in western blot on mouse samples at 1:2000 (fig 4). Nat Commun (2016) ncbi
mouse monoclonal (23/Fatty Acid Synthase)
  • immunohistochemistry; human; 1:500; loading ...; fig 6
  • western blot; human; loading ...; fig 4D
BD Biosciences fatty acid synthase antibody (BD Transduction Laboratories, 610962) was used in immunohistochemistry on human samples at 1:500 (fig 6) and in western blot on human samples (fig 4D). Oncogenesis (2015) ncbi
mouse monoclonal (23/Fatty Acid Synthase)
  • immunohistochemistry - paraffin section; mouse; fig 2
BD Biosciences fatty acid synthase antibody (bD Bioscience, 610962) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (23/Fatty Acid Synthase)
  • immunohistochemistry - paraffin section; mouse
BD Biosciences fatty acid synthase antibody (BD Bioscience, 610962) was used in immunohistochemistry - paraffin section on mouse samples . Am J Physiol Endocrinol Metab (2014) ncbi
Articles Reviewed
  1. Helmrich N, Roderfeld M, Baier A, Windhorst A, Herebian D, Mayatepek E, et al. Pharmacologic Antagonization of Cannabinoid Receptor 1 Improves Cholestasis in Abcb4-/- Mice. Cell Mol Gastroenterol Hepatol. 2022;13:1041-1055 pubmed publisher
  2. Nuernberger V, Mortoga S, Metzendorf C, Burkert C, Ehricke K, Knuth E, et al. Hormonally Induced Hepatocellular Carcinoma in Diabetic Wild Type and Carbohydrate Responsive Element Binding Protein Knockout Mice. Cells. 2021;10: pubmed publisher
  3. Carroll P, Freie B, Cheng P, Kasinathan S, Gu H, Hedrich T, et al. The glucose-sensing transcription factor MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis. PLoS Biol. 2021;19:e3001085 pubmed publisher
  4. Wang X, Yung M, Sharma R, Chen F, Poon Y, Lam W, et al. Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis. Cancers (Basel). 2021;13: pubmed publisher
  5. Chu J, Xing C, Du Y, Duan T, Liu S, Zhang P, et al. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication. Nat Metab. 2021;3:1466-1475 pubmed publisher
  6. Gyamfi J, Yeo J, Kwon D, Min B, Cha Y, Koo J, et al. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer. NPJ Breast Cancer. 2021;7:129 pubmed publisher
  7. Cheng C, Xue F, Sui W, Meng L, Xie L, Zhang C, et al. Deletion of natriuretic peptide receptor C alleviates adipose tissue inflammation in hypercholesterolemic Apolipoprotein E knockout mice. J Cell Mol Med. 2021;25:9837-9850 pubmed publisher
  8. Guo W, Liu J, Cheng L, Liu Z, Zheng X, Liang H, et al. Metformin Alleviates Steatohepatitis in Diet-Induced Obese Mice in a SIRT1-Dependent Way. Front Pharmacol. 2021;12:704112 pubmed publisher
  9. Tomacha J, Dokduang H, Padthaisong S, Namwat N, Klanrit P, Phetcharaburanin J, et al. Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression. Front Pharmacol. 2021;12:696961 pubmed publisher
  10. Li L, Yang Q, Jiang Y, Yang W, Jiang Y, Li X, et al. Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer. Nat Commun. 2021;12:4362 pubmed publisher
  11. Jiang D, Zhang J, Lin S, Wang Y, Chen Y, Fan J. Prolyl Endopeptidase Gene Disruption Improves Gut Dysbiosis and Non-alcoholic Fatty Liver Disease in Mice Induced by a High-Fat Diet. Front Cell Dev Biol. 2021;9:628143 pubmed publisher
  12. Ma N, Wang Y, Xu S, Ni Q, Zheng Q, Zhu B, et al. PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling. Nat Commun. 2021;12:3059 pubmed publisher
  13. Zhao Z, Wang Z, Zhou D, Han Y, Ma F, Hu Z, et al. Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene. Cell Mol Gastroenterol Hepatol. 2021;12:857-871 pubmed publisher
  14. Zhang M, Ceyhan Y, Kaftanovskaya E, Vasquez J, Vacher J, Knop F, et al. INPP4B protects from metabolic syndrome and associated disorders. Commun Biol. 2021;4:416 pubmed publisher
  15. Galbraith L, Mui E, Nixon C, Hedley A, Strachan D, Mackay G, et al. PPAR-gamma induced AKT3 expression increases levels of mitochondrial biogenesis driving prostate cancer. Oncogene. 2021;40:2355-2366 pubmed publisher
  16. Aregger M, Lawson K, Billmann M, Costanzo M, Tong A, Chan K, et al. Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism. Nat Metab. 2020;2:499-513 pubmed publisher
  17. Feng Y, Mischler W, Gurung A, Kavanagh T, Androsov G, Sadow P, et al. Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis. Cancer Res. 2020;80:2751-2763 pubmed publisher
  18. Viscarra J, Wang Y, Nguyen H, Choi Y, Sul H. Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis. Nat Commun. 2020;11:796 pubmed publisher
  19. Bueno M, Jimenez Renard V, Samino S, Capellades J, Junza A, López Rodríguez M, et al. Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells. Nat Commun. 2019;10:5011 pubmed publisher
  20. Presby D, Checkley L, Jackman M, Higgins J, Jones K, Giles E, et al. Regular exercise potentiates energetically expensive hepatic de novo lipogenesis during early weight regain. Am J Physiol Regul Integr Comp Physiol. 2019;317:R684-R695 pubmed publisher
  21. Choi W, Kim H, Kim M, Cinar R, Yi H, Eun H, et al. Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis. Cell Metab. 2019;30:877-889.e7 pubmed publisher
  22. Guo Z, Zhao K, Feng X, Yan D, Yao R, Chen Y, et al. mTORC2 Regulates Lipogenic Gene Expression through PPARγ to Control Lipid Synthesis in Bovine Mammary Epithelial Cells. Biomed Res Int. 2019;2019:5196028 pubmed publisher
  23. Ma X, Cheng F, Yuan K, Jiang K, Zhu T. Lipid storage droplet protein 5 reduces sodium palmitate‑induced lipotoxicity in human normal liver cells by regulating lipid metabolism‑related factors. Mol Med Rep. 2019;20:879-886 pubmed publisher
  24. Che L, Chi W, Qiao Y, Zhang J, Song X, Liu Y, et al. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans. Gut. 2020;69:177-186 pubmed publisher
  25. Su L, Zhou L, Chen F, Wang H, Qian H, Sheng Y, et al. Cideb controls sterol-regulated ER export of SREBP/SCAP by promoting cargo loading at ER exit sites. EMBO J. 2019;38: pubmed publisher
  26. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed publisher
  27. Guo J, Fang W, Chen X, Lin Y, Hu G, Wei J, et al. Upstream stimulating factor 1 suppresses autophagy and hepatic lipid droplet catabolism by activating mTOR. FEBS Lett. 2018;592:2725-2738 pubmed publisher
  28. Hartl D, May P, Gu W, Mayhaus M, Pichler S, Spaniol C, et al. A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease. Mol Psychiatry. 2018;: pubmed publisher
  29. Li T, Song L, Sun Y, Li J, Yi C, Lam S, et al. Tip60-mediated lipin 1 acetylation and ER translocation determine triacylglycerol synthesis rate. Nat Commun. 2018;9:1916 pubmed publisher
  30. Liakath Ali K, Mills E, Sequeira I, Lichtenberger B, Pisco A, Sipilä K, et al. An evolutionarily conserved ribosome-rescue pathway maintains epidermal homeostasis. Nature. 2018;556:376-380 pubmed publisher
  31. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  32. Li S, Mi L, Yu L, Yu Q, Liu T, Wang G, et al. Zbtb7b engages the long noncoding RNA Blnc1 to drive brown and beige fat development and thermogenesis. Proc Natl Acad Sci U S A. 2017;114:E7111-E7120 pubmed publisher
  33. Al Khalaf H, Amir M, Al Mohanna F, Tulbah A, Al Sayed A, Aboussekhra A. Obesity and p16INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity. Mol Cell Biol. 2017;37: pubmed publisher
  34. Bai X, Hong W, Cai P, Chen Y, Xu C, Cao D, et al. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis. Toxicol Appl Pharmacol. 2017;324:12-25 pubmed publisher
  35. Song Z, Xiaoli A, Zhang Q, Zhang Y, Yang E, Wang S, et al. Cyclin C regulates adipogenesis by stimulating transcriptional activity of CCAAT/enhancer-binding protein ?. J Biol Chem. 2017;292:8918-8932 pubmed publisher
  36. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  37. Viscarra J, Wang Y, Hong I, Sul H. Transcriptional activation of lipogenesis by insulin requires phosphorylation of MED17 by CK2. Sci Signal. 2017;10: pubmed publisher
  38. Kim I, Nam T. Enzyme-treated Ecklonia cava extract inhibits adipogenesis through the downregulation of C/EBP? in 3T3-L1 adipocytes. Int J Mol Med. 2017;39:636-644 pubmed publisher
  39. Che L, Pilo M, Cigliano A, Latte G, Simile M, Ribback S, et al. Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma. Cell Cycle. 2017;16:499-507 pubmed publisher
  40. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed publisher
  41. Dey P, Baddour J, Muller F, Wu C, Wang H, Liao W, et al. Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. Nature. 2017;542:119-123 pubmed publisher
  42. Stein S, Lemos V, Xu P, Demagny H, Wang X, Ryu D, et al. Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease. J Clin Invest. 2017;127:583-592 pubmed publisher
  43. Steffen J, Vashisht A, Wan J, Jen J, Claypool S, Wohlschlegel J, et al. Rapid degradation of mutant SLC25A46 by the ubiquitin-proteasome system results in MFN1/2-mediated hyperfusion of mitochondria. Mol Biol Cell. 2017;28:600-612 pubmed publisher
  44. Lizardo K, Almonte V, Law C, Aiyyappan J, Cui M, Nagajyothi J. Diet regulates liver autophagy differentially in murine acute Trypanosoma cruzi infection. Parasitol Res. 2017;116:711-723 pubmed publisher
  45. Marmisolle I, Martínez J, Liu J, Mastrogiovanni M, Fergusson M, Rovira I, et al. Reciprocal regulation of acetyl-CoA carboxylase 1 and senescence in human fibroblasts involves oxidant mediated p38 MAPK activation. Arch Biochem Biophys. 2017;613:12-22 pubmed publisher
  46. Liu L, Guan H, Li Y, Ying Z, Wu J, Zhu X, et al. Astrocyte Elevated Gene 1 Interacts with Acetyltransferase p300 and c-Jun To Promote Tumor Aggressiveness. Mol Cell Biol. 2017;37: pubmed publisher
  47. Liu Z, Gan L, Wu T, Feng F, Luo D, Gu H, et al. Adiponectin reduces ER stress-induced apoptosis through PPARα transcriptional regulation of ATF2 in mouse adipose. Cell Death Dis. 2016;7:e2487 pubmed publisher
  48. Bendre S, Rondelet A, Hall C, Schmidt N, Lin Y, Brouhard G, et al. GTSE1 tunes microtubule stability for chromosome alignment and segregation by inhibiting the microtubule depolymerase MCAK. J Cell Biol. 2016;215:631-647 pubmed
  49. Sulek J, Robinson S, Petrossian A, Zhou S, Goliadze E, Manjili M, et al. Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model. Prostate. 2017;77:361-373 pubmed publisher
  50. Hinds T, Burns K, Hosick P, McBeth L, Nestor Kalinoski A, Drummond H, et al. Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3? Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) ?. J Biol Chem. 2016;291:25179-25191 pubmed
  51. Haney S, Upchurch G, Opavska J, Klinkebiel D, Appiah A, Smith L, et al. Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice. Sci Rep. 2016;6:34222 pubmed publisher
  52. Yang Z, Tsuchiya H, Zhang Y, Lee S, Liu C, Huang Y, et al. REV-ERB? Activates C/EBP Homologous Protein to Control Small Heterodimer Partner-Mediated Oscillation of Alcoholic Fatty Liver. Am J Pathol. 2016;186:2909-2920 pubmed publisher
  53. Serviddio G, Bellanti F, Villani R, Tamborra R, Zerbinati C, Blonda M, et al. Effects of dietary fatty acids and cholesterol excess on liver injury: A lipidomic approach. Redox Biol. 2016;9:296-305 pubmed publisher
  54. Gabriel K, Jones A, Nguyen J, Antillon K, Janos S, Overton H, et al. Association and regulation of protein factors of field effect in prostate tissues. Int J Oncol. 2016;49:1541-1552 pubmed publisher
  55. Jenny Zhou H, Qin L, Zhang H, Tang W, Ji W, He Y, et al. Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation. Nat Med. 2016;22:1033-1042 pubmed publisher
  56. Cader M, Boroviak K, Zhang Q, Assadi G, Kempster S, Sewell G, et al. C13orf31 (FAMIN) is a central regulator of immunometabolic function. Nat Immunol. 2016;17:1046-56 pubmed publisher
  57. Jeong H, Cho Y, Kim K, Kim Y, Kim K, Na Y, et al. Anti-lipoapoptotic effects of Alisma orientalis extract on non-esterified fatty acid-induced HepG2 cells. BMC Complement Altern Med. 2016;16:239 pubmed publisher
  58. Zinkhan E, Zalla J, Carpenter J, Yu B, Yu X, Chan G, et al. Intrauterine growth restriction combined with a maternal high-fat diet increases hepatic cholesterol and low-density lipoprotein receptor activity in rats. Physiol Rep. 2016;4: pubmed publisher
  59. Shinohara S, Gu Y, Yang Y, Furuta Y, Tanaka M, Yue X, et al. Ethanol extracts of chickpeas alter the total lipid content and expression levels of genes related to fatty acid metabolism in mouse 3T3-L1 adipocytes. Int J Mol Med. 2016;38:574-84 pubmed publisher
  60. Geng F, Cheng X, Wu X, Yoo J, Cheng C, Guo J, et al. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis. Clin Cancer Res. 2016;22:5337-5348 pubmed
  61. Tong X, Li P, Zhang D, VanDommelen K, Gupta N, Rui L, et al. E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis. J Lipid Res. 2016;57:1219-30 pubmed publisher
  62. Karlas A, Berrè S, Couderc T, Varjak M, Braun P, Meyer M, et al. A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs. Nat Commun. 2016;7:11320 pubmed publisher
  63. Gómez SanMiguel A, Villanúa M, Martín A, López Calderón A. D-TRP(8)-γMSH Prevents the Effects of Endotoxin in Rat Skeletal Muscle Cells through TNFα/NF-KB Signalling Pathway. PLoS ONE. 2016;11:e0155645 pubmed publisher
  64. Rapiteanu R, Davis L, Williamson J, Timms R, Paul Luzio J, Lehner P. A Genetic Screen Identifies a Critical Role for the WDR81-WDR91 Complex in the Trafficking and Degradation of Tetherin. Traffic. 2016;17:940-58 pubmed publisher
  65. Thomas A, Belaidi E, Aron Wisnewsky J, van der Zon G, Levy P, Clement K, et al. Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice. Sci Rep. 2016;6:24618 pubmed publisher
  66. Nishikido T, Oyama J, Shiraki A, Komoda H, Node K. Deletion of Apoptosis Inhibitor of Macrophage (AIM)/CD5L Attenuates the Inflammatory Response and Infarct Size in Acute Myocardial Infarction. J Am Heart Assoc. 2016;5:e002863 pubmed publisher
  67. Wang C, Chen Y, Wang C, Yu J, Chang Y, Yu C. mTOR regulates proteasomal degradation and Dp1/E2F1- mediated transcription of KPNA2 in lung cancer cells. Oncotarget. 2016;7:25432-42 pubmed publisher
  68. Senol Cosar O, Flach R, DiStefano M, Chawla A, Nicoloro S, Straubhaar J, et al. Tenomodulin promotes human adipocyte differentiation and beneficial visceral adipose tissue expansion. Nat Commun. 2016;7:10686 pubmed publisher
  69. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  70. Lee K, Hsieh Y, Yang Y, Chan C, Huang Y, Lin H. Aliskiren Reduces Hepatic steatosis and Epididymal Fat Mass and Increases Skeletal Muscle Insulin Sensitivity in High-Fat Diet-Fed Mice. Sci Rep. 2016;6:18899 pubmed publisher
  71. Nemazanyy I, Montagnac G, Russell R, Morzyglod L, Burnol A, Guan K, et al. Class III PI3K regulates organismal glucose homeostasis by providing negative feedback on hepatic insulin signalling. Nat Commun. 2015;6:8283 pubmed publisher
  72. Brina D, Miluzio A, Ricciardi S, Clarke K, Davidsen P, Viero G, et al. eIF6 coordinates insulin sensitivity and lipid metabolism by coupling translation to transcription. Nat Commun. 2015;6:8261 pubmed publisher
  73. Bollu L, Katreddy R, Blessing A, Pham N, Zheng B, Wu X, et al. Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation. Oncotarget. 2015;6:34992-5003 pubmed publisher
  74. Jung Y, Kim H, Koo J. Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer. PLoS ONE. 2015;10:e0137204 pubmed publisher
  75. Dettlaff Pokora A, Sledzinski T, Swierczynski J. Up-Regulation Mttp and Apob Gene Expression in Rat Liver is Related to Post-Lipectomy Hypertriglyceridemia. Cell Physiol Biochem. 2015;36:1767-77 pubmed
  76. Zidek L, Ackermann T, Hartleben G, Eichwald S, Kortman G, Kiehntopf M, et al. Deficiency in mTORC1-controlled C/EBPβ-mRNA translation improves metabolic health in mice. EMBO Rep. 2015;16:1022-36 pubmed publisher
  77. Zeng X, Wang H, Bai F, Zhou X, Li S, Ren L, et al. Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream target. Br J Pharmacol. 2015;172:4303-18 pubmed publisher
  78. Wang W, Snyder N, Worth A, Blair I, Witze E. Regulation of lipid synthesis by the RNA helicase Mov10 controls Wnt5a production. Oncogenesis. 2015;4:e154 pubmed publisher
  79. Li S, Oh Y, Yue P, Khuri F, Sun S. Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells. Oncogene. 2016;35:642-50 pubmed publisher
  80. Koizume S, Ito S, Nakamura Y, Yoshihara M, Furuya M, Yamada R, et al. Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer. Mol Cancer. 2015;14:77 pubmed publisher
  81. Li X, Tao J, Cigliano A, Sini M, Calderaro J, Azoulay D, et al. Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver. Oncotarget. 2015;6:10102-15 pubmed
  82. Kumari A, Owen N, Juarez E, McCullough A. BLM protein mitigates formaldehyde-induced genomic instability. DNA Repair (Amst). 2015;28:73-82 pubmed publisher
  83. Kim S, Lee Y, Koo J. Differential expression of lipid metabolism-related proteins in different breast cancer subtypes. PLoS ONE. 2015;10:e0119473 pubmed publisher
  84. Woo J, Zhao X, Khan H, Penn C, Wang X, Joly Amado A, et al. Slingshot-Cofilin activation mediates mitochondrial and synaptic dysfunction via Aβ ligation to β1-integrin conformers. Cell Death Differ. 2015;22:921-34 pubmed publisher
  85. Kang O, Kim S, Mun S, Seo Y, Hwang H, Lee Y, et al. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes. Int J Mol Med. 2015;35:803-9 pubmed publisher
  86. Bollu L, Ren J, Blessing A, Katreddy R, Gao G, Xu L, et al. Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells. Cell Cycle. 2014;13:2415-30 pubmed publisher
  87. Shimizu H, Astapova I, Ye F, Bilban M, Cohen R, Hollenberg A. NCoR1 and SMRT play unique roles in thyroid hormone action in vivo. Mol Cell Biol. 2015;35:555-65 pubmed publisher
  88. Kretzschmar K, Cottle D, Donati G, Chiang M, Quist S, Gollnick H, et al. BLIMP1 is required for postnatal epidermal homeostasis but does not define a sebaceous gland progenitor under steady-state conditions. Stem Cell Reports. 2014;3:620-33 pubmed publisher
  89. DiTommaso T, Cottle D, Pearson H, Schlüter H, Kaur P, Humbert P, et al. Keratin 76 is required for tight junction function and maintenance of the skin barrier. PLoS Genet. 2014;10:e1004706 pubmed publisher
  90. Daniëls V, Smans K, Royaux I, Chypre M, Swinnen J, Zaidi N. Cancer cells differentially activate and thrive on de novo lipid synthesis pathways in a low-lipid environment. PLoS ONE. 2014;9:e106913 pubmed publisher
  91. Mottillo E, Balasubramanian P, Lee Y, Weng C, Kershaw E, Granneman J. Coupling of lipolysis and de novo lipogenesis in brown, beige, and white adipose tissues during chronic β3-adrenergic receptor activation. J Lipid Res. 2014;55:2276-86 pubmed publisher
  92. Liu J, Zheng L, Wu N, Ma L, Zhong J, Liu G, et al. Oleanolic acid induces metabolic adaptation in cancer cells by activating the AMP-activated protein kinase pathway. J Agric Food Chem. 2014;62:5528-37 pubmed publisher
  93. Suburu J, Shi L, Wu J, Wang S, Samuel M, Thomas M, et al. Fatty acid synthase is required for mammary gland development and milk production during lactation. Am J Physiol Endocrinol Metab. 2014;306:E1132-43 pubmed publisher
  94. Lanaspa M, Ishimoto T, Li N, Cicerchi C, Orlicky D, Ruzycki P, et al. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun. 2013;4:2434 pubmed publisher
  95. De Sousa Coelho A, Relat J, Hondares E, Pérez Martí A, Ribas F, Villarroya F, et al. FGF21 mediates the lipid metabolism response to amino acid starvation. J Lipid Res. 2013;54:1786-97 pubmed publisher
  96. Antony N, Weir J, McDougall A, Mantamadiotis T, Meikle P, Cole T, et al. cAMP response element binding protein1 is essential for activation of steroyl co-enzyme a desaturase 1 (Scd1) in mouse lung type II epithelial cells. PLoS ONE. 2013;8:e59763 pubmed publisher